Overview

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
To investigates the effects of combined pharmacotherapy with solifenacin and mirabegron versus solifenacin with vaginal estrogen cream in women with detrusor overactivity.
Phase:
Phase 4
Details
Lead Sponsor:
Mackay Memorial Hospital
Treatments:
Estrogens
Solifenacin Succinate